Taysha Gene Therapies, Inc. · NASDAQ:TSHA
Goldman Sachs Group Inc reported a 5.10% stake in Taysha Gene Therapies, Inc. (Schedule 13G)
Event Jun 26, 2025 · Filed Jul 3, 2025
Goldman Sachs Group Inc reported a 5.10% stake in Taysha Gene Therapies, Inc., 12,748,968 shares, as a passive investor on Jun 26, 2025. Filed Jul 3, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 12,748,968
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 5.10% | 12,748,968 |
| GOLDMAN SACHS & CO. LLC | 5.10% | 12,748,968 |
Source
Related
- Taysha Gene Therapies, Inc.
- Goldman Sachs Group Inc
- Taysha Gene Therapies, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Morgan Stanley · Aug 13, 2026
- Form 4 · Nagendran Sukumar · Jul 10, 2026
- Form 4 · Stalfort John A III · Jun 2, 2026
- Form 4 · Donenberg Phillip B. · Jun 2, 2026